Safety and efficacy of intensive systolic blood pressure lowering after successful endovascular therapy: a post hoc analysis of the BP TARGET trial
Conclusion
The effect of SBP lowering treatment was not modified by age, location of occlusion history of hypertension, intravenous thrombolysis, and admission SBP. Diabetes modified the effect of intensive SBP lowering treatment, and there was a trend towards benefit from intensive SBP treatment in diabetic patients. This finding is hypothesis generating and requires further validation.
Source: Journal of NeuroInterventional Surgery - Category: Neurosurgery Authors: Anadani, M., Maier, B., Escalard, S., Labreuche, J., de Havenon, A., Sabben, C., Lapergue, B., Mistry, E. A., Gory, B., Spiotta, A. M., Richard, S., Sibon, I., Desilles, J.-P., Blanc, R., Piotin, M., Mazighi, M., of behalf the BP TARGET study group, Mazig Tags: Ischemic stroke Source Type: research
More News: Brain | Diabetes | Endocrinology | Hemorrhagic Stroke | Hypertension | Ischemic Stroke | Neurology | Neurosurgery | Stroke | Study